Heart failure with reduced ejection fraction (HFrEF) remains a major public health burden, with persistent morbidity and mortality despite advances in contemporary guideline-directed medical therapy (GDMT).1,2 Soluble guanylate cyclase…

Heart failure with reduced ejection fraction (HFrEF) remains a major public health burden, with persistent morbidity and mortality despite advances in contemporary guideline-directed medical therapy (GDMT).1,2 Soluble guanylate cyclase…